Other Briefings
Amendments to Malaysia’s Employment Act to Come into Force January 1, 2023
The proposed amendments to Malaysia’s Employment Act hopes to bring the act to international standards as required by the ILO and others.
Malaysia Makes Amendments to its Patent Act: Key Highlights
Malaysia has made amendments to its Patent Act to ensure that its patent protection laws are in line with international standards.
Malaysia Extends Income Tax Incentive Applications for the East Coast Economic Region
Malaysia has extended the timeline for applicants seeking income tax incentives for qualifying activities in the East Coast Economic Region.
2023 Investment Opportunities in Malaysia
Malaysia has been a major recipient of Chinese investment and the country’s geostrategic position has made it a hub for many red-chip Chinese businesses.
Changes to Merger and Acquisition Rules in Malaysia
Malaysia has made changes to its merger and acquisition rules to increase flexibility and transparency and improve regulatory enforcement.
Electric Vehicles in Malaysia: Tax Incentives for Owners and Manufacturers
As of January 2022, electric vehicle producers in Malaysia can enjoy a variety of tax incentives, such as tax exemptions for imports, excise, and sales.
Malaysia Enhances Incentives for Businesses Looking to Establish a Principal Hub
Malaysia has enhanced incentives for businesses looking to establish a principal/regional hub in the country.
Malaysia Increases Minimum Wage from May 1, 2022: What are the Implications for Businesses?
Malaysia will increase the national monthly minimum wage from May 1, 2022, by 25 percent from 1,200 ringgit (US$276) to 1,500 ringgit (US$345).
Malaysia’s Border Reopening: Boost for Tourism Sector, Hiring in Palm Oil Industry
We discuss how Malaysia’s border reopening will benefit the tourism and palm oil production industries and list the updated entry requirements.
Tax Incentives for Pharmaceutical Manufacturers in Malaysia: How Can Businesses Qualify?
Malaysia will continue to accept applications for tax incentives from pharmaceutical manufacturers until December 31, 2022.
